Medical Technology Group calls for debate citing “half a billion pounds” potential savings
UK’s NICE agrees technology is more effective than current practice in improving adherence to asthma medication
Report says new regs not a challenge, downward pricing pressure welcome and emerging markets not an opportunity… not really
It’s estimated that 340,000 French women have received silicone gel breast implants in France since their introduction in 2001. Only appropriate then, that the regulators should review the state of play, especially in view of the PIP scandal.
Artificial muscle is so much harder to develop than any number of joints or even organs like heart valves. After all, muscles need to be active rather than passive participants in making bodily things happen. A U.S. research team has published its efforts in this month’s Science journal and they sound promising.
Researchers have developed intricately patterned 3D tissue constructs with multiple types of cells and tiny blood vessels. The work could provide tissues that are realistic enough to screen drugs for safety and effectiveness. Ultimately it offers the potential for reconstructive surgery.
The UK’s National Institute for Health Research (NIHR) has issued a technical report pointing to the potential for Veryan Medical’s BioMimics 3D™ Stent. It focuses on the potential advantage of a spiral stent that mimics the shape of a native vessel, but being a government body rather ducks the issue of whether it’s any good, leaving us wondering what use this report really is.
Who’s responsible for ensuring devices get used correctly, according to manufacturers’ instructions? A new survey suggests companies might have to work harder to educate vascular specialists about how to get best results from peripheral drug-eluting balloons.
Medtronic, Inc. today issued a press release in which it acknowledged the publication of the findings from Yale University’s third-party, … continue reading “INFUSE® Bone Graft Review Leaves Questions”
Assessing the impact of medtech innovation on rising healthcare expenditure requires looking beyond cost alone, according to new research.
A recent Europe-wide survey of Anaesthetists, delivered by UK medical device research firm Creative Medical Research, claims to have revealed the views of the profession in relation to existing and future technologies.
Smith & Nephew has revealed in-vitro study results suggesting ACTICOAT Silver-Coated Antimicrobial Dressings are bactericidal against some antibiotic resistant organisms carrying the NDM-1 enzyme, often referred to as ‘superbugs’.
Collaborative research performed between the Universities of Edinburgh and Southampton has resulted in a material that combines a plastic scaffold with the potential for stem cell regeneration of bone. It’s hoped the development may result in an expanded ability to repair bone in the most traumatic fracture cases involving bone loss.
Mussel-inspired adhesives have been proposed before in surgical applications, the chemistry employed by the shellfish to anchor them to rocks being considered transferable to the operating room. A new article from Pennsylvania State University researchers brings things up to date.
GI Dynamics has announced that it has entered into separate research collaborations with GlaxoSmithKline and Medtronic in an effort to understanding how EndoBarrier® works in relation to diabetes.
So despite initiative after initiative, the leviathon that is the NHS, the institution that above all others needs to have professional procurement infrastructure, sounds like a basket case of in-fighting, suspicion of the private sector and no outcome controls. So says a new expert report.